Alyeska Investment Group, L.P. Reata Pharmaceuticals Inc Transaction History

Alyeska Investment Group, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$79.22 - $105.37 $4.04 Million - $5.37 Million	50,982 New	50,982 $5.2 Million
Q1 2018 May 15, 2018	SELL	$20.0 - $30.19 $1.07 Million - $1.61 Million	-53,252 Reduced 25.9%	152,323 $3.12 Million
Q4 2017 Feb 14, 2018	BUY	$22.39 - $33.27 $2.56 Million - $3.81 Million	114,527 Added 125.79%	205,575 $5.82 Million
Q3 2017 Nov 14, 2017	BUY	$26.29 - $31.88 $2.39 Million - $2.9 Million	91,048	91,048 $2.83 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.